Novel biomarkers and therapeutic approaches for diabetic retinopathy and nephropathy: Recent progress and future perspectives

The global burden due to microvascular complications in patients with diabetes mellitus persists and even increases alarmingly, the intervention and management are now encountering many difficulties and challenges. This paper reviews the recent advancement and progress in novel biomarkers, artificia...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Ziyan, Xiao, Xinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732104/
https://www.ncbi.nlm.nih.gov/pubmed/36506068
http://dx.doi.org/10.3389/fendo.2022.1065856
_version_ 1784846056225243136
author Xie, Ziyan
Xiao, Xinhua
author_facet Xie, Ziyan
Xiao, Xinhua
author_sort Xie, Ziyan
collection PubMed
description The global burden due to microvascular complications in patients with diabetes mellitus persists and even increases alarmingly, the intervention and management are now encountering many difficulties and challenges. This paper reviews the recent advancement and progress in novel biomarkers, artificial intelligence technology, therapeutic agents and approaches of diabetic retinopathy and nephropathy, providing more insights into the management of microvascular complications.
format Online
Article
Text
id pubmed-9732104
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97321042022-12-10 Novel biomarkers and therapeutic approaches for diabetic retinopathy and nephropathy: Recent progress and future perspectives Xie, Ziyan Xiao, Xinhua Front Endocrinol (Lausanne) Endocrinology The global burden due to microvascular complications in patients with diabetes mellitus persists and even increases alarmingly, the intervention and management are now encountering many difficulties and challenges. This paper reviews the recent advancement and progress in novel biomarkers, artificial intelligence technology, therapeutic agents and approaches of diabetic retinopathy and nephropathy, providing more insights into the management of microvascular complications. Frontiers Media S.A. 2022-11-25 /pmc/articles/PMC9732104/ /pubmed/36506068 http://dx.doi.org/10.3389/fendo.2022.1065856 Text en Copyright © 2022 Xie and Xiao https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Xie, Ziyan
Xiao, Xinhua
Novel biomarkers and therapeutic approaches for diabetic retinopathy and nephropathy: Recent progress and future perspectives
title Novel biomarkers and therapeutic approaches for diabetic retinopathy and nephropathy: Recent progress and future perspectives
title_full Novel biomarkers and therapeutic approaches for diabetic retinopathy and nephropathy: Recent progress and future perspectives
title_fullStr Novel biomarkers and therapeutic approaches for diabetic retinopathy and nephropathy: Recent progress and future perspectives
title_full_unstemmed Novel biomarkers and therapeutic approaches for diabetic retinopathy and nephropathy: Recent progress and future perspectives
title_short Novel biomarkers and therapeutic approaches for diabetic retinopathy and nephropathy: Recent progress and future perspectives
title_sort novel biomarkers and therapeutic approaches for diabetic retinopathy and nephropathy: recent progress and future perspectives
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732104/
https://www.ncbi.nlm.nih.gov/pubmed/36506068
http://dx.doi.org/10.3389/fendo.2022.1065856
work_keys_str_mv AT xieziyan novelbiomarkersandtherapeuticapproachesfordiabeticretinopathyandnephropathyrecentprogressandfutureperspectives
AT xiaoxinhua novelbiomarkersandtherapeuticapproachesfordiabeticretinopathyandnephropathyrecentprogressandfutureperspectives

Ejemplares similares